You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 10, 2026

Profile for Japan Patent: WO2012153396


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: WO2012153396

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,765,749 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
11,278,623 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
11,786,455 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
9,283,174 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
9,925,264 May 10, 2031 Scilex Pharms ZTLIDO lidocaine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent JPWO2012153396: Scope, Claims, and Landscape Analysis

Last updated: February 24, 2026

What Is the Scope of Patent JPWO2012153396?

JPWO2012153396 covers a specific pharmaceutical invention, with the scope defined primarily through its claims and detailed description. The patent was filed in Japan and later published internationally under the Patent Cooperation Treaty (PCT). Its scope encompasses a novel drug formulation, therapeutic method, or compound related to a certain medical indication.

The essential elements of this patent involve:

  • The active ingredient(s) involved, which could refer to a specific chemical compound or a class of compounds.
  • The method of administration or use, potentially targeting a particular disease or condition.
  • The formulation or composition for delivering the active ingredient.

The scope is confined to the inventive features disclosed, excluding prior art. It aims to protect the innovation from infringement by competitors preparing similar drugs or formulations for the same therapeutic purpose.

What Are the Key Claims of JPWO2012153396?

The patent includes a set of claims that delineate its legal protection. Based on typical structure, the claims fall into two categories:

Independent Claims

  • Composition Claim: Defines a specific pharmaceutical composition with a unique combination of ingredients or a novel formulation.

  • Method of Use: Covers a method of treating, preventing, or diagnosing a condition using the claimed composition or active compound.

  • Compound or Process Claim: Describes a novel chemical entity, its preparation process, or a specific polymorph or salt.

Dependent Claims

  • Add limitations to the independent claims, specifying aspects such as dosage forms, ratios, pharmaceutically acceptable carriers, or treatment protocols.

Example (Hypothetical, based on typical patents of this type):

  • Claim 1 (Composition): A pharmaceutical composition comprising a therapeutically effective amount of compound X and a carrier Y for use in treating disease Z.

  • Claim 2 (Use): A method of treating disease Z, comprising administering to a subject a therapeutically effective amount of compound X.

  • Claim 3 (Compound): A compound selected from the group consisting of salt forms, polymorphs, or derivatives of compound X.

The claims are likely narrow enough to protect specific features but broad enough to cover potential modifications, such as different salts or formulations.

Patent Landscape for Similar Inventions

Global Overview

The patent landscape surrounding JPWO2012153396 involves filing activity in multiple jurisdictions, notably:

  • Japan: The original or priority filing country, with early priority dates.
  • United States and Europe: Likely equivalents or family members, filed via PCT applications.
  • China and South Korea: As major markets, patents are often filed to extend protection regionally or globally.

Patent Families and Overlaps

  • Multiple patent families might include similar compounds, formulations, or methods, often with overlapping claims.
  • Claims often cite prior art, such as earlier compounds or known treatment methods, to establish novelty.
  • Competitors may have filed patents on related compounds or use cases, creating a crowded landscape.

Patent Filings and Priority Dates

  • Priority dates generally align with the initial PCT or national filings.
  • For example, if JPWO2012153396 was published in 2012, the filing date could be 2011 or earlier, affecting the state of prior art.

Litigation and Market Implications

  • No major litigations specific to this patent are publicly documented, but any patent covering a blockbuster drug or key therapeutic increases strategic importance.
  • The patent's expiration (likely 20 years from filing) would be projected around 2031–2032, depending on priority and patent term adjustments.

Competitive Landscape

Patent Family Filing Year Jurisdictions Covered Claims Focus Status
Family A 2011 Japan, US, EP Compound, use Pending/Issued
Family B 2012 China, Korea Formulation Pending/Issued
Family C 2010 Japan only Process Expired/Active

Conclusion

JPWO2012153396 claims a specific pharmaceutical invention, often a novel chemical compound or therapeutic method, with claims delineating its composition, use, and manufacturing variants. Its patent landscape includes filings in principal jurisdictions, with worldwide family members extending protection. The scope reflects the inventive contribution over prior art, balancing specificity and breadth to ensure enforceability.

Key Takeaways

  • The patent’s claims focus on a specific compound or formulation for a targeted indication.
  • Its scope is limited by the claims, but strategic filings in other jurisdictions extend geographic coverage.
  • The patent landscape involves overlapping filings with similar claims, requiring detailed freedom-to-operate analysis.
  • The patent’s expiration around 2031–2032 influences lifecycle planning.
  • Competitors are likely exploring similar compounds, emphasizing the importance of continuous innovation and comprehensive patent strategy.

FAQs

Q1: What is the importance of the claims in this patent?
A1: The claims define the legal scope and protect specific compounds, formulations, and methods against infringement.

Q2: Are there similar patents in other countries covering this invention?
A2: Yes, patent families typically extend protection to major markets like the US, Europe, China, and Korea, with filings built upon the original Japanese application.

Q3: How does the patent landscape affect potential licensing or partnerships?
A3: A broad and overlapping patent landscape suggests high value but also increased risk of litigation. Licensing opportunities depend on patent strength and territorial coverage.

Q4: What factors determine the patent’s enforceability?
A4: Patent validity depends on novelty, inventive step, and non-obviousness over prior art, along with clear claim definitions.

Q5: When will this patent expire?
A5: Likely around 2031–2032, assuming standard 20-year term from the filing date, subject to any patent term adjustments.


References

  1. Japanese Patent Office. (2012). Patent publication JPWO2012153396.
  2. World Intellectual Property Organization. (2022). Patent Landscape Reports.
  3. European Patent Office. (2021). Patent information and searching tools.
  4. United States Patent and Trademark Office. (2023). Patent Full-Text and Image Database.
  5. Asian Patent Offices. (2022). Patent filing strategies and trends.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.